泰林生物收盘上涨2.69%，滚动市盈率203.21倍，总市值21.76亿元

Company Overview - Zhejiang Tailin Biological Technology Co., Ltd. specializes in microbial testing and pollution control, innovative drug research and production, process analysis, and protective measures in the life sciences sector [2] - The company provides high-quality products and solutions for industries such as biomedicine, healthcare, food and beverage, and environmental protection [2] Financial Performance - For Q1 2025, the company reported revenue of 66.94 million yuan, a year-on-year decrease of 16.33% [2] - The net profit for the same period was 3.53 million yuan, down 39.93% year-on-year, with a sales gross margin of 49.27% [2] Market Position - As of May 6, the company's stock closed at 17.95 yuan, up 2.69%, with a rolling price-to-earnings (PE) ratio of 203.21, marking a new low in 20 days [1] - The average PE ratio in the medical device industry is 48.90, with a median of 36.41, placing Tailin Biological at the 116th position in the industry ranking [1][3] Shareholder Information - As of March 31, 2025, the number of shareholders for Tailin Biological was 11,553, a decrease of 294 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1]